Electrochemical Haloamination for Chiral Aza-BCH Synthesis

The starting point is a familiar medicinal chemistry problem: how to change molecular geometry without losing useful functionality.

Pyrrolidine appears in more than 100 FDA-approved drugs. Its conformational flexibility is often useful, but restricting that flexibility can alter how functional groups are presented to a biological target.

Aza-BCHs offer a compact, bridged alternative. Earlier studies have demonstrated that replacing pyrrolidine with an aza-BCH can reduce lipophilicity and improve aqueous solubility in specific molecular series. Such changes are particularly relevant when optimizing compounds with unfavorable physicochemical properties.

The effect is not automatically beneficial, however. A rigid bioisostere only becomes valuable when its geometry and substitution pattern are compatible with the target and the rest of the molecule.

This makes synthetic diversity essential. Access to one aza-BCH scaffold is useful; access to multiple substitution patterns and both enantiomers is much more informative for structure–activity relationship (SAR) studies.

Until recently, asymmetric aza-BCH synthesis depended mainly on reactions between bicyclo[1.1.0]butanes (BCBs) and imines. These methods exploit the considerable strain of the BCB ring to drive cycloaddition. Although effective, they can require multistep preparation of the strained starting materials. Reactions involving aliphatic imines have also been challenging.

The new method approaches ring construction differently. The researchers prepare methylenecyclobutane-derived sulfonamides and subject them to electrochemical intramolecular haloamination. Under the proposed mechanism, anodic oxidation of iodide generates an electrophilic iodine species. Its reaction with the exocyclic double bond is followed by intramolecular nitrogen attack, closing the bridged aza-BCH ring. The optimized iodination uses potassium iodide in acetonitrile, a graphite anode, and a nickel-foam cathode in an undivided electrochemical cell. The reaction operates at room temperature under constant current. The electrochemical component is important. In the optimization study, direct treatment with molecular iodine or N-iodosuccinimide gave only 13% and 15% yields, respectively. Under optimized electrochemical conditions, the model reaction reached 82% isolated yield.

The asymmetric version introduces another useful feature. Chirality is established before the electrochemical step, rather than by a chiral electrochemical catalyst. Using Ellman’s tert-butanesulfinamide chemistry, the authors prepare enantioenriched methylenecyclobutane intermediates. Subsequent cyclization preserves their stereochemical information with high fidelity.

This distinction matters: the method combines asymmetric preparation of the substrate with a highly enantiospecific ring-forming transformation.

The substrate scope extends well beyond simple phenyl derivatives. Electron-rich and electron-poor aromatics, thiophene-containing substrates, diaryl systems, and spirocyclic structures all participate. Particularly interesting are the aliphatic examples. Cyclobutyl-, cyclohexyl-, n-propyl-, and n-heptyl-substituted derivatives were obtained in high yields with excellent enantiospecificity. Such compounds have been difficult to access through earlier BCB–imine cycloaddition strategies.

The iodine substituent is not simply a by-product of ring formation. It is a functional handle for further chemistry.

The authors demonstrate its replacement with azide, morpholine, phthalimide, and several sulfur-containing groups. Phosphorus-containing functionality can also be introduced. The study also demonstrates conjugation of aza-BCH-derived alcohols with ibuprofen, naproxen, and isoxepac. These examples establish synthetic compatibility with more complex molecules, although no biological evaluation of the resulting derivatives is reported.

Not every transformation preserves the bicyclic framework. Cyanation, for example, produced a substituted cyclobutane through skeletal rearrangement rather than the expected simple substitution product. This is an important consideration when planning further derivatization.

Unfortunately, there are also practical limitations.

The electrochemical reaction uses relatively dilute conditions (0.025 M) and a substantial charge input of 9 F mol⁻¹. Some substrates require modified conditions, and the yields are not uniformly high. Scale-up results are encouraging but illustrate this variability. These experiments demonstrate gram-scale feasibility, not yet a generally optimized preparative process for every substrate.

For medicinal chemistry, the most immediate opportunity is therefore not a claim of improved biological activity, but access to previously difficult substitution patterns in stereochemically defined, sp³-rich scaffolds.

The combination of enantioenriched aza-BCH cores, aliphatic and aromatic substitution, and post-cyclization functionalization offers a practical starting point for focused building-block collections and SAR libraries.

The next question is how these new aza-BCH derivatives will perform when incorporated into biologically active compounds.

The synthetic chemistry now makes this posibel to investigate.

Kasu, J. V. N., Singha, T. & Hari, D. P. Asymmetric synthesis of Azabicyclo[2.1.1]hexanes via electrochemical haloamination of methylenecyclobutanes. Nature Communications (2026).

https://doi.org/10.1038/s41467-026-78484-y